Differential roles of p300 and PCAF acetyltransferases in muscle differentiation

Molecular Cell

Volumn 1, Issue 1, 1997, Pages 35-45

  Puri, Pier Lorenzo ^a,g   Sartorelli, Vittorio ^b,c   Yang, Xiang Jiao ^d   Hamamori, Yasuo ^b   Ogryzko, Vasily V ^d   Howard, Bruce H ^d   Kedes, Larry ^b   Wang, Jean Y J ^g   Graessmann, Adolf ^e   Nakatani, Yoshihiro ^d   Levrero, Massimo ^a,f  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c UNIVERSITY OF BRESCIA   (Italy)

^d EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^e FREIE UNIVERSITÄT BERLIN   (Germany)

^f UNIVERSITY OF CAGLIARI   (Italy)

^g UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYL COENZYME A ACYLTRANSFERASE; ACYLTRANSFERASE; CELL CYCLE PROTEIN; CREBBP PROTEIN, MOUSE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; E1A ASSOCIATED P300 PROTEIN; EP300 PROTEIN, MOUSE; HISTONE ACETYLTRANSFERASE; HISTONE ACETYLTRANSFERASE PCAF; MULTIENZYME COMPLEX; MYOD PROTEIN; NUCLEAR PROTEIN; P300-CBP-ASSOCIATED FACTOR; PCAF PROTEIN, MOUSE; RNA POLYMERASE II; SACCHAROMYCES CEREVISIAE PROTEIN; TRANSACTIVATOR PROTEIN; TRANSCRIPTION FACTOR; VIRUS T ANTIGEN;

ANIMAL; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CHEMISTRY; CYTOLOGY; DRUG EFFECT; ENZYMOLOGY; GENE EXPRESSION REGULATION; METABOLISM; MOUSE; MUSCLE CELL; PHYSIOLOGY; SKELETAL MUSCLE; TRANSACTIVATION;

ACETYL-COA C-ACYLTRANSFERASE; ACETYLTRANSFERASES; ANIMALS; ANTIGENS, VIRAL, TUMOR; CELL CYCLE PROTEINS; CELL DIFFERENTIATION; CELLS, CULTURED; CREB-BINDING PROTEIN; E1A-ASSOCIATED P300 PROTEIN; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HISTONE ACETYLTRANSFERASES; MICE; MULTIENZYME COMPLEXES; MUSCLE FIBERS; MUSCLE, SKELETAL; MYOD PROTEIN; NUCLEAR PROTEINS; RNA POLYMERASE II; SACCHAROMYCES CEREVISIAE PROTEINS; TRANS-ACTIVATION (GENETICS); TRANS-ACTIVATORS; TRANSCRIPTION FACTORS;

EID: 0031310741     PISSN: 10972765     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1097-2765(00)80005-2     Document Type: Article

References (49)

1. Arias, J., Alberts, A.S., Brindle, P., Claret, F.X., Smeal, T., Karin, M., Feramisco, J., and Montminy, M. (1994). Activation of cAMP and mitogen responsive genes relies on a common nuclear factor. Nature 370, 226-229.
2. Avantaggiati, M.L., Carbone, M., Graessmann, A., Nakatani, Y., Howard, B., and Levine, A.S. (1996). The SV40 large T antigen and adenovirus E1a oncoproteins interact with distinct isoforms of the transcriptional co-activator, p300. EMBO J. 15, 2236-2248.
3. Avantaggiati, M.L. Ogryzko, V., Gardner, K., Giordano, A., Levine, A.S., and Kelly, K. (1997). Recruitment of p300/CBP in p53-dependent signal pathways. Cell 89, 1175-1164.
4. Bannister, A.J., and Kouzarides, T. (1996). The CBP co-activator is a histone acetyltransferase. Nature 384, 641-643
5. Brownell, J.E.,and Allis, C.D. (1996). Special HATs for special occasions: linking histone acetylation to chromatin assembly and gene activation. Curr. Opin. Genet. Dev. 6, 176-184.
6. Brownell, J.E., Zhou, J., Ranalli, T., Kobayashi, R., Edmondson, D.G., Roth, S.Y., and Allis, C.D. (1996). Tetrahymena histone acetyltransferase A: a homolog to yeast Gcn5p linking histone acetylation to gene activation. Cell 84, 843-851.
7. Caruso, M., Martelli, F., Giordano, A., and Felsani, A. (1993). Regulation of MyoD gene transcription and protein function by the transforming domains of the adenovirus E1A oncoprotein. Oncogene 8, 267-278.
8. Chen, H., Lin, R.J., Schiltz, R.L., Chakravarti, D., Nash, A., Nagy, L., Privalsky, M.L., Nakatani, Y., and Evans, R.M. (1997). Nuclear receptor co-activator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300. Cell 90, 569-580.
9. Eckner, R., Yao, T.P., Oldread, E., and Livingston, D.M. (1996). Interaction and functional collaboration of p300/CBP and bHLH factors in muscle and B-cell differentiation. Genes Dev. 10, 2478-2490.
10. El Deiry, W.S., Tokino, T., Velculescu, V.E., Levy, D.B., Parsons, R., Trent, J.M., Lin, D., Mercer W.E., Kinzler, K.W., and Vogelstein, B. (1993). WAF1 a potential mediator of p53 tumor suppression. Cell 75, 817-825.
11. Giordano, A., McCall, C., Whyte, P., and Franza, B.J. (1991). Human cyclin A and the retinoblastoma protein interact with similar but distinguishable sequences in the adenovirus E1A gene product. Oncogene 6, 481-485.
12. Graessmann, M., and Graessmann, A. (1983). Microinjection of tissue culture cells. Meth. Enzymol. 101, 482-492.
13. Gu, W., and Roeder, R.G. (1997). Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell 90, 595-606.
14. Gu, W., Shi, X.-L., and Roeder, R.G. (1997). Synergistic activation of transcription by CBP and p53. Nature 387, 819-823.
15. Guo, K., Wang J., Andes, V., Smith, R.C., and Walsh, K. (1995). MyoD induced expression of p21 inhibits cyclin-dependent kinase activity upon myocyte terminal differentiation. Mol. Cell. Biol. 15, 3823-3829.
16. Halevy O., Novitch, B.G., Spicer, D.B., Skapek, S.X., Rhee J., Hannon, G.J., Beach, D., and Lassar, A.B. (1995). Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science 267, 1018-1021.
17. Janknecht, R., and Hunter, T. (1996). A growing coactivator network. Nature 383, 22-23.
18. Lassar, A.B., and Munsterberg, A. (1994). Wiring diagrams: regulatory circuits and the control of skeletal myogenesis. Curr. Biol. 6, 432-442.
19. Lee, J.S., Galvin, K.M., See, R.H., Eckner, R., Livingston, D., Moran, E., and Shi, Y. (1995). Relief of YY1 transcriptional repression by adenovirus E1A is mediated by E1A-associated protein. Genes Dev. 9, 1188-1198
20. Lill, N.L., Grossman, S.R., Ginsberg, D., DeCaprio, J., and Livingston, D.M. (1997). Binding and modulation of p53 by p300/CBP coactivators. Nature 387, 823-827.
21. ∥250 subunit of TFIID has histone acetyltransferase activity. Cell 87, 1261-1270.
22. Molkentin, J.D., Black, B.L., Martin, J.F., and Olson, E.N. (1995). Cooperative activation of muscle gene expression by MEF2 and myogenic bHLH factors. Cell 83, 1125-1136.
23. Moran, E. (1993). DNA tumor virus transforming proteins and the cell cycle. Curr. Opin. Genet. Dev. 3, 63-70.
24. Mymryk, J.S., Lee, R.W., and Bayley, S.T. (1992). Ability of adenovirus 5 E1A proteins to suppress differentiation of BC3H1 myoblasts correlates with their binding to a 300 kDa cellular protein. Mol. Biol. Cell 3, 1107-1115.
25. Nakajima, T., Uchida, C., Anderson, S.F., Parvin, J.D., and Montminy, M. (1997a). Analysis of a cAMP-responsive activator reveals a two-componentmechanism for transcriptional induction via signal-dependent factors. Genes Dev. 11, 738-747.
26. Nakajima, T., Uchida, C., Anderson, S.F., Lee, C.-G., Hurwitz, J., Parvin, J.D., and Montminy, M. (1997b). RNA helicase A mediates association of CBP with RNA polymerase II. Cell 90, 1107-1112.
27. Nevins, J.R. (1992). E2F: a link between the Rb tumor suppressor protein and viral oncoproteins. Science 258, 424-429.
28. Ogryzko, V.V., Schiltz, R.L., Russanova, V., Howard, B.H., and Nakatani, Y. (1996). The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell 87, 953-959.
29. Orphanides, G., Lagrange, T., and Reinberg, D. (1996). The general initiation factors of RNA polymerase II. Genes Dev. 10, 2657-2683.
30. Parker, S.B., Eichele G., Zhang, P., Rawls, A., Sands AT., Bradley, A., Olson, E., Harper, J.W., and Elledge, S.J. (1995). p53-independent expression of p21 in muscle and other terminally differentiated cells. Science 267, 1024-1027.
31. Pazin, M.J., and Kadonaga, J.T. (1997). What's up and down with histone deacetylation and transcription? Cell 89, 325-328.
32. Ptashne, M., and Gann, A. (1997). Transcriptional activation by recruitment. Nature 386, 569-577.
33. Puri, P.L., Avantaggiati, M.L., Balsano, C., Sang, N., Graessmann, A., Giordano, A., and Levrero, M. (1997). p300 is required for MyoD-dependent cell cycle arrest and muscle-specific gene transcription. EMBO J. 16, 369-383.
34. Reeves, R., Gorman, C.M., and Howard, B.H. (1985). Minichromosome assembly of non-integrated DNA transfected into mammalian cells. Nucleic Acids Res. 13, 3599-3615.
35. Roeder, R.G. (1996). The role of general initiation factors in transcription by RNA polymerase II. Trends Biochem. Sci. 21, 327-335.
36. Rudnicki, M.A., Braun,T., Hinuma, S., and Jaenisch, R. (1992). Inactivation of MyoD in mice leads to up-regulation of the myogenic HLH gene Myf-5 and results in apparently normal muscle development. Cell 71, 383-390.
37. Rudnicki, M.A., Schnegelsberg, P.N., Stead, R.H., Braun, T., Arnold, H.H., and Jaenisch, R. (1993). MyoD or Myf-5 is required for the formation of skeletal muscle. Cell 75, 1351-1359.
38. Sartorelli, V., Huang, J., Hamamori, Y., and Kedes, L. (1997). Molecular mechanisms of myogenic coactivation by p300: direct interaction with the activation domain of MyoD and with the MADS box of MEF2C. Mol. Cell. Biol. 17, 1010-1026.
39. Spencer, T.E., Jenster, G., Burcin, M.M., Allis, C.D., Zhou, J., Mizzen, C.A., McKenna, N.J., Onate, S.A., Tsai, S.Y., Tsai, M.-J., and O'Malley, B.W. (1997). Steroid receptor coactivator-1 is a histone acetyltransferase. Nature 389, 194-198.
40. Tedesco, D., Caruso, M., Fischer, F.L., and Vesco, C. (1995). The inhibition of cultured myoblast differentiation by the simian virus 40 large T antigen occurs after myogenin expression and Rb upregulation and is not exerted by transformation-competent cytoplasmic mutants. J. Virol. 69, 6947-6957.
41. Turner, B.M.,and O'Neill, L.P. (1995). Histone acetylation in chromatin and chromosomes. Semin. Cell Biol. 6, 229-236.
42. Wang, H.G., Rikitake, Y., Carter, M.C., Yaciuk, P., Abraham, S.E., Zerler, B., and Moran, E. (1993a). Identification of specific adenovirus E1AN-terminal residues critical to the binding of cellular proteins and to the control of cell growth. J. Virol. 67, 476-488.
43. Wang, H.G., Yaciuk, P., Ricciardi, R.P., Green, M., Yokoyama, K., and Moran, E. (1993b). The E1A products of oncogenic adenovirus serotype 12 include amino-terminally modified forms able to bind the retinoblastoma protein but not p300. J. Virol. 67, 4804-4813.
44. Webster, K.A., Muscat, G.E., and Kedes, L. (1988). Adenovirus E1A products suppress myogenic differentiation and inhibit transcription from muscle-specific promoters. Nature 332, 553-557.
45. Wolffe, A.P. (1994). The transcription of chromatin templates. Curr. Opin. Genet. Dev. 4, 245-254.
46. Wolffe, A.P., and Pruss, D. (1996). Targeting chromatin disruption: transcription regulators that acetylate histones. Cell 84, 817-819.
47. Wolffe, A.P. (1997). Transcriptional control. Sinful repression. Nature 387, 16-17.
48. Yang, X.-J., Ogryzko, V.V., Nishikawa, J., Howard, B.H., and Nakatani, Y. (1996). A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A. Nature 382, 319-324.
49. Yuan, W., Condorelli, G., Caruso, M., Felsani, A., and Giordano, A. (1996). Human p300 protein is a coactivator for the transcription factor MyoD. J. Biol. Chem. 271, 9009-9013.